Lumos Diagnostics Holdings Limited
LDXHF
$0.16
$0.00-0.93%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 0.43% | |||
| Cost of Revenue | 0.00% | -25.89% | |||
| Gross Profit | 0.00% | 20.73% | |||
| SG&A Expenses | 0.00% | 34.30% | |||
| Depreciation & Amortization | 0.00% | 7.43% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 18.09% | |||
| Operating Income | 0.00% | -41.49% | |||
| Income Before Tax | 0.00% | -11.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | -11.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | -11.44% | |||
| EBIT | 0.00% | -41.49% | |||
| EBITDA | 0.00% | -21.87% | |||
| EPS Basic | 0.00% | -10.34% | |||
| Normalized Basic EPS | 0.00% | -11.11% | |||
| EPS Diluted | 0.00% | -10.34% | |||
| Normalized Diluted EPS | 0.00% | -11.11% | |||
| Average Basic Shares Outstanding | 0.00% | 3.35% | |||
| Average Diluted Shares Outstanding | 0.00% | 3.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||